BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16797723)

  • 1. Immunopathogenic pathways in canine inflammatory myopathies resemble human myositis.
    Shelton GD; Hoffman EP; Ghimbovschi S; Peters IR; Day MJ; Mullins M; Moore PF; Nagaraju K
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):200-14. PubMed ID: 16797723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
    Raju R; Dalakas MC
    Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From dog to man: the broad spectrum of inflammatory myopathies.
    Shelton GD
    Neuromuscul Disord; 2007 Oct; 17(9-10):663-70. PubMed ID: 17629703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine inflammatory myopathy: analysis of cellular infiltrates.
    Pumarola M; Moore PF; Shelton GD
    Muscle Nerve; 2004 Jun; 29(6):782-9. PubMed ID: 15170610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy.
    Salvadori C; Peters IR; Day MJ; Engvall E; Shelton GD
    Muscle Nerve; 2005 Feb; 31(2):192-8. PubMed ID: 15736299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcolemma-specific autoantibodies in canine inflammatory myopathy.
    Hankel S; Shelton GD; Engvall E
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):1-10. PubMed ID: 16824619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications.
    Greenberg SA
    Neurology; 2007 Nov; 69(21):2008-19. PubMed ID: 17928577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in idiopathic inflammatory myopathies.
    Salomonsson S; Lundberg IE
    Autoimmunity; 2006 May; 39(3):177-90. PubMed ID: 16769651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.
    Cantarini L; Volpi N; Carbotti P; Greco G; Aglianò M; Bellisai F; Giannini F; Alessandrini C; Grasso G; Galeazzi M
    J Clin Pathol; 2009 May; 62(5):442-7. PubMed ID: 19139036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
    Neumann J; Bilzer T
    Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines and dendritic cells in inflammatory myopathies.
    Tournadre A; Miossec P
    Ann Rheum Dis; 2009 Mar; 68(3):300-4. PubMed ID: 19213746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
    Greenberg SA; Pinkus JL; Pinkus GS; Burleson T; Sanoudou D; Tawil R; Barohn RJ; Saperstein DS; Briemberg HR; Ericsson M; Park P; Amato AA
    Ann Neurol; 2005 May; 57(5):664-78. PubMed ID: 15852401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serotonergic system in the pathogenesis of fibrosis in canine idiopathic inflammatory myopathies.
    Pavone LM; Rea S; Trapani F; De Pasquale V; Tafuri S; Papparella S; Paciello O
    Neuromuscul Disord; 2012 Jun; 22(6):549-57. PubMed ID: 22397866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
    Megens-de Letter MA; Visser LH; van Doorn PA; Savelkoul HF
    Eur Cytokine Netw; 1999 Dec; 10(4):471-8. PubMed ID: 10586113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle pathology in 2 siblings infected with Toxoplasma gondii.
    Calore EE; Minkovski R; Khoury Z; Seguro AC; Perez Calore NM; Cavaliere MJ
    J Rheumatol; 2000 Jun; 27(6):1556-9. PubMed ID: 10852291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.
    Grundtman C; Malmström V; Lundberg IE
    Arthritis Res Ther; 2007; 9(2):208. PubMed ID: 17389031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction.
    Nagaraju K; Casciola-Rosen L; Lundberg I; Rawat R; Cutting S; Thapliyal R; Chang J; Dwivedi S; Mitsak M; Chen YW; Plotz P; Rosen A; Hoffman E; Raben N
    Arthritis Rheum; 2005 Jun; 52(6):1824-35. PubMed ID: 15934115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM; Reed AM
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.